iCAD to Present at the 9th Annual LD Micro Main Event

LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today that it will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7th at 8:00 AM PST / 11:00 AM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Ken Ferry, Chief Executive Officer, Rich Christopher, Executive Vice President and Chief Financial Officer, and Stacey Stevens, Executive Vice President of Marketing and Strategy, will be presenting, as well as meeting with investors.

Event: 9th Annual LD Micro Main Event
Date: Wednesday, December 7th, 2016
Time: 8:00 a.m. PT / 11:00 a.m. ET

The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.

Audio webcasts of the Company’s presentations will be available online at http://wsw.com/webcast/ldmicro11/icad. Replays of the presentations will be available for 90 days.

View iCAD’s profile here: http://www.ldmicro.com/profile/iCAD

News Compliments of Accesswire

About iCAD, Inc.

iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a comprehensive range of upgradeable computer-aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared, CE marked, and licensed in a growing number of countries for the treatment of cancer anywhere in the body, including treatment of early-stage breast cancer, gynecological cancers and non-melanoma skin cancer. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. For more information, visit or www.icadmed.com or www.xoftinc.com.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com/events for more information.

Contact:

For iCAD investor relations:
The Ruth Group
Name: Zack Kubow
Phone: 646-536-7030
Address: San Francisco, CA
Email: zkubow@theruthgroup.com

For iCAD media inquiries:
Berry & Company Public Relations, LLC
Name: Jessica Burns
Phone: 212-253-8881
Address: New York, NY
Email: jburns@berrypr.com

SOURCE: iCAD via LD Micro

ReleaseID: 450062